荷兰2022年秋季COVID-19加强针接种率相关因素:≥60岁老年人及18-59岁有慢性病成年人
荷兰于2022年秋季为≥60岁人群和18-59岁有严重COVID-19医疗风险因素的人群提供二价COVID-19疫苗加强针。研究通过全国登记数据关联分析发现,加强针接种率在≥60岁人群中为68%,在18-59岁医疗风险人群中为30%。随机森林分析显示年龄是两组最重要的决定因素,进步自由派政党投票比例排名第二。
要点
- ≥60岁人群加强针接种率为68%,18-59岁医疗风险人群为30%。
- 年龄是两组加强针接种最重要的决定因素,18-29岁接种率15%,80岁以上为72%。
- 进步自由派政党投票比例排名第二,比例越高接种率越高。
核心结论
- ≥60岁目标人群的加强针接种覆盖率远高于18-59岁医疗风险目标人群。
- 两个目标人群内部各亚组的接种率差异很大。
- 研究结果可用于未来疫苗接种策略以及进一步研究低接种率亚组的驱动和障碍因素。
研究设计与样本
- 研究人群为既往至少接种过一剂COVID-19疫苗的个体。
- 2022年秋季加强针定义为2022年9月19日至2023年3月7日期间接种COVID-19疫苗。
- 通过唯一个人标识符关联全国社会人口学决定因素登记和COVID-19疫苗接种登记。
- 政党投票比例以社区水平纳入分析。
- 采用随机森林分析对加强针接种决定因素按重要性排序。
主要发现
- ≥60岁人群加强针接种率为68%,18-59岁有严重疾病医疗风险因素人群为30%。
- 两组中年龄均为最重要的决定因素,接种率从18-29岁的15%升至80岁以上的72%。
- 进步自由派政党投票比例在随机森林分析中两组均排名第二,投票比例增加与更高接种率相关。
- ≥60岁组中家庭类型排名第三,无子女已婚夫妇接种率最高(72%),有子女未婚伴侣最低(47%)。
- 医疗风险组中移民状态排名第三,父母均出生国外的移民接种率最低(18%),父母均出生荷兰的移民最高(35%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A booster with bivalent COVID-19 vaccine was offered in the Netherlands in autumn, 2022. We aimed to investigate vaccine uptake during the autumn 2022 booster round among the population subgroups at risk for severe COVID-19 that were specifically targeted by this campaign: the medical risk group aged 18-59 years and individuals ≥ 60 years. We calculated booster uptake in both populations and analyzed determinants of booster uptake among those who had received at least one prior COVID-19 vaccination. METHODS: Having had an autumn 2022 booster dose was defined as having received a COVID-19 vaccination between 19 September 2022 and 7 March 2023. The study population included individuals who received at least one previous COVID-19 vaccination. National registries of sociodemographic determinants and COVID-19 vaccination were linked by a unique person identifier. Voting proportions for political parties were included at neighborhood level. Determinants of COVID-19 vaccine autumn booster uptake were ranked by importance by random forest analyses. RESULTS: Booster uptake was 68 % among those aged ≥ 60 and 30 % among those aged 18-59 years with a medical risk factor for severe disease. For both target groups the most important determinant for booster uptake was age (15 % in 18-29 years to 72 % in 80 + years). Voting proportions for progressive liberal political parties ranked second in the random forest analysis in both groups, with an increasing proportion of votes associated with higher uptake. In the 60 + group, household type ranked third, with highest vaccine uptake among married couples without children (72 %) and the lowest uptake among unmarried couples with children (47 %). In the medical risk group, migration status ranked third. Migrants with two parents born abroad had the lowest uptake (18 %), whereas migrants with both parents born in the Netherlands had the highest uptake (35 %). CONCLUSION: The target group of people aged ≥ 60 years was much better reached than the target group of people with a medical risk aged 18-59 years. Uptake varied considerably among subgroups in both target groups. The findings of this study can be used in future vaccination strategies as well as for further research to better understand the drivers and barriers of vaccine uptake among the subgroups with notably low uptake.
引用
- van Roekel C, Labuschagne L, Pijpers J, et al. Factors associated with COVID-19 autumn 2022 booster uptake in the Netherlands among older adults aged ≥ 60 years and younger adults with chronic conditions. Vaccine. 2023. PMID: 38101955. doi:10.1016/j.vaccine.2023.12.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。